Viloxazine in the Treatment of Attention Deficit Hyperactivity Disorder

Viloxazine in the Treatment of Attention Deficit Hyperactivity Disorder

Attention deficit hyperactivity disorder (ADHD) is the most common neurodevelopmental disorder in children. Over the past twenty years, research on the disease and its characteristics and treatment options has grown exponentially. The first-line pharmacologic treatment of ADHD is stimulants, which h...

Full description

Bibliographic Details
Main Authors: Amber N. Edinoff, Haseeb A. Akuly, John H. Wagner, Megan A. Boudreaux, Leah A. Kaplan, Shadman Yusuf, Elisa E. Neuchat, Elyse M. Cornett, Andrea G. Boyer, Adam M. Kaye, Alan D. Kaye
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-12-01
Series:Frontiers in Psychiatry
Subjects:
viloxazine
ADHD
non-stimulant
neuropsychiatric disorder
pediatrics
serotonin-norepinephrine modulating agent
Online Access:https://www.frontiersin.org/articles/10.3389/fpsyt.2021.789982/full

Internet

https://www.frontiersin.org/articles/10.3389/fpsyt.2021.789982/full

Similar Items